Menu Search
Equities

Yield10 Bioscience Inc

YTEN:QBB

Yield10 Bioscience Inc

Actions
  • Price (USD)0.50
  • Today's Change-0.025 / -4.76%
  • Shares traded619.00
  • 1 Year change-90.39%
  • Beta1.5118
Data delayed at least 15 minutes, as of Nov 22 2024 19:37 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Yield10 Bioscience Inc's revenues fell -86.67% from 450.00k to 60.00k. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 13.57m to a larger loss of 14.46m.
Gross margin--
Net profit margin-1,693.60%
Operating margin-1,679.07%
Return on assets-287.44%
Return on equity--
Return on investment--
More ▼

Cash flow in USDView more

In 2023, cash reserves at Yield10 Bioscience Inc fell by 1.29m. Cash Flow from Financing totalled 6.87m or 11,451.67% of revenues. In addition the company used 10.07m for operations while cash from investing totalled 1.95m.
Cash flow per share-32.30
Price/Cash flow per share--
Book value per share-9.71
Tangible book value per share-9.71
More ▼

Balance sheet in USDView more

Yield10 Bioscience Inc uses little or no debt in its capital structure.
Current ratio0.157
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.